Table 3. Unadjusted and adjusted regression analysis in MS patients.
| Unadjusted | Adjusted | |||||||
|---|---|---|---|---|---|---|---|---|
| β | 95%CI | p | β | 95%CI | p | |||
| BPF | 0.26 | (0.03, | 0.49) | 0.03 | 0.26 | (0.00, | 0.51) | 0.047 |
| EDSS—High Severity (Low) | -0.02 | (-0.04, | 0.01) | 0.20 | -0.02 | (-0.05, | 0.01) | 0.15 |
| Duration MS | -0.04 | (-0.17, | 0.08) | 0.52 | 0.00 | (-0.13, | 0.13) | 0.98 |
| Duration Treatment | -0.01 | (-0.05, | 0.03) | 0.49 | -0.02 | (-0.06, | 0.02) | 0.27 |
| Age (years) | 0.00 | (0.00, | 0.00) | 0.42 | ||||
| BMI | 0.00 | (0.00, | 0.00) | 0.38 | ||||
| Sex—Male (Female) | -0.03 | (-0.06, | 0.00) | 0.06 | ||||
| Race—Black (White) | 0.00 | (-0.03, | 0.02) | 0.81 | ||||
Analyses were run twice, the first model contained only MS disease characteristics and the second model adjusted for patient demographic characteristics (n = 52).